Inhibition of protein kinase C-mu (PKD) as a treatment for cardiac hypertrophy and heart failure

Details for Australian Patent Application No. 2004249114 (hide)

Owner Board of Regents, The University of Texas System Myogen, Inc.

Inventors Olson, Eric; Vega, Rick B.; McKinsey, Timothy A.

Agent Pizzeys

Pub. Number AU-A-2004249114

PCT Pub. Number WO2004/112763

Priority 60/472,298 21.05.03 US

Filing date 19 May 2004

Wipo publication date 29 December 2004

International Classifications

A61K 031/00

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/112763 Priority application(s): WO2004/112763

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249116-Flexible liquid absorbing structure

2004249102-Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol